Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,563,142

« Back to Dashboard

Summary for Patent: 5,563,142

Title: Diaromatic substituted compounds as anti-HIV-1 agents
Abstract:The present invention includes diaromatic substituted heterocyclic compounds (III) ##STR1## which are useful in treating individuals infected with the HIV virus.
Inventor(s): Palmer; John R. (Kalamazoo, MI), Romero; Donna L. (Kalamazoo, MI), Aristoff; Paul A. (Kalamazoo, MI), Thomas; Richard C. (Kalamazoo, MI), Smith; Herman W. (Kalamazoo, MI)
Assignee: The Upjohn Company (Kalamazoo, MI)
Application Number:08/198,428
Patent Claim Types:
see list of patent claims
Compound;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Viiv Hlthcare
RESCRIPTOR
delavirdine mesylate
TABLET;ORAL020705Apr 4, 1997RXNo5,563,142<disabled>
Viiv Hlthcare
RESCRIPTOR
delavirdine mesylate
TABLET;ORAL020705Jul 14, 1999RXYes5,563,142<disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,563,142

Country Document Number Publication Date
WIPO (PCT)9109849Jul 11, 1991
United States5489593Feb 06, 1996
Russia2099335Dec 20, 1997
Mexico9203454Aug 01, 1992
Latvia10264Oct 20, 1994
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc